Drugs Controller General Of India
-
{
- All
- News
- Videos
-
After Pharma Firm's Huge Eye Drop Claim, Regulator Withdraws Permission
Taking serious note of Mumbai-based Entod Pharmaceuticals' claims that it can help reduce dependency on reading glasses for those suffering from presbyopia, the Drugs Controller General of India (DGCI) has suspended permission given to the company.
-
Only Processing Charges To Be Levied For Procuring Blood At Hospitals, Blood Banks: Drug Regulator
Hospitals and blood banks can now only charge processing fees for blood as the apex drug regulator has decided to do away with all other fees to check the practice of overcharging.
-
Drugs Regulator Says Will Prioritise Making Regulation System Simpler
Drugs Controller General of India (DCGI) Rajeev Singh Raghuvanshi on Thursday said bringing down regulatory intervention in the system and making it simpler is a top priority for the organisation.
-
AstraZeneca Pharma's Cancer-Treating Drug Gets Regulator's Nod In India
AstraZeneca Pharma India Ltd on Wednesday said it has received an approval from the Drug Controller General of India (DCGI) for the cancer drug trastuzumab deruxtecan for treatment of metastatic breast cancer.
-
Critical Drug Developed Using DRDO Technology Gets Regulator's Approval
A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India (DCGI), the defence ministry said on Tuesday.
-
India Drug Regulator Allows Serum Insititute To Export Its Malaria Vaccine To UK
India's drug regulator has allowed the export of the first produced-in-India vaccine against malaria, developed by scientists at the University of Oxford and manufactured by Serum Institute to the UK.
-
CBI's "Trap Operation" In Drug Regulator Office Over Bribery Case
The CBI on Monday apprehended some persons at the office of the Drugs Controller General of India in connection with a Rs three lakh alleged bribery case in which the role of Joint Drugs Controller S Eswara Reddy is under scanner, officials said.
-
Covovax Gets Emergency Use Approval For Children Above 12 Years
India's drug regulator has granted restricted emergency use authorisation to Serum Institute of India's COVID-19 vaccine Covovax for the 12-17 years age group subject to certain conditions, official sources said on Wednesday.
-
Covid Vaccines Covishield, Covaxin Get Conditional Market Approval: Report
India's drug regulator has granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, Health Minister Mansukh Mandaviya said today.
-
India-Made RT-PCR Kit To Detect Omicron Gets Approval: Centre
An RT-PCR test kit for detecting new coronavirus variant Omicron has been developed in India in partnership with Tata MD and the Indian Council of Medical Research (ICMR), said Dr Balram Bhargava, Director General of ICMR on Wednesday.
-
Centre Forms Panel To Frame New Law For Drugs, Cosmetics, Medical Devices
The government has constituted an eight-member panel to frame a new law for drugs, cosmetics and medical devices. The panel is being headed by Drugs Controller General of India (DCGI) Dr VG Somani.
-
Study On Mixing Covaxin, Covishield Gets Drug Regulator Approval
A study on mixing Covishield and Covaxin, the two main vaccines used in India's COVID-19 vaccination programme, has been given the go-ahead by the Drugs Controller General Of India (DCGI).
-
Drug Regulator Examining Zydus Cadila's Covid Vaccine For Children: Dr VK Paul
Drugs Controller General of India (DCGI) is examining pharmaceutical major Zydus Cadila's COVID-19 vaccine for children, said Dr VK Paul, Member-Health, Niti Aayog on Friday.
-
Foreign Vaccines Like Pfizer, Moderna A Step Closer With Key India Waiver
In a big move to clear the way for foreign vaccines like Pfizer and Moderna, the drug regulator has done away with the requirement of India-specific trials.
-
Need Of 3rd Anti-Covid Dose Based More Upon Conjecture Than Data: Experts
More data is needed to establish if a third anti-COVID-19 booster dose will more effectively help in fighting the surge in infections in the country as currently its requirement has been based more upon conjecture, health experts said.
-
After Pharma Firm's Huge Eye Drop Claim, Regulator Withdraws Permission
Taking serious note of Mumbai-based Entod Pharmaceuticals' claims that it can help reduce dependency on reading glasses for those suffering from presbyopia, the Drugs Controller General of India (DGCI) has suspended permission given to the company.
-
Only Processing Charges To Be Levied For Procuring Blood At Hospitals, Blood Banks: Drug Regulator
Hospitals and blood banks can now only charge processing fees for blood as the apex drug regulator has decided to do away with all other fees to check the practice of overcharging.
-
Drugs Regulator Says Will Prioritise Making Regulation System Simpler
Drugs Controller General of India (DCGI) Rajeev Singh Raghuvanshi on Thursday said bringing down regulatory intervention in the system and making it simpler is a top priority for the organisation.
-
AstraZeneca Pharma's Cancer-Treating Drug Gets Regulator's Nod In India
AstraZeneca Pharma India Ltd on Wednesday said it has received an approval from the Drug Controller General of India (DCGI) for the cancer drug trastuzumab deruxtecan for treatment of metastatic breast cancer.
-
Critical Drug Developed Using DRDO Technology Gets Regulator's Approval
A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India (DCGI), the defence ministry said on Tuesday.
-
India Drug Regulator Allows Serum Insititute To Export Its Malaria Vaccine To UK
India's drug regulator has allowed the export of the first produced-in-India vaccine against malaria, developed by scientists at the University of Oxford and manufactured by Serum Institute to the UK.
-
CBI's "Trap Operation" In Drug Regulator Office Over Bribery Case
The CBI on Monday apprehended some persons at the office of the Drugs Controller General of India in connection with a Rs three lakh alleged bribery case in which the role of Joint Drugs Controller S Eswara Reddy is under scanner, officials said.
-
Covovax Gets Emergency Use Approval For Children Above 12 Years
India's drug regulator has granted restricted emergency use authorisation to Serum Institute of India's COVID-19 vaccine Covovax for the 12-17 years age group subject to certain conditions, official sources said on Wednesday.
-
Covid Vaccines Covishield, Covaxin Get Conditional Market Approval: Report
India's drug regulator has granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, Health Minister Mansukh Mandaviya said today.
-
India-Made RT-PCR Kit To Detect Omicron Gets Approval: Centre
An RT-PCR test kit for detecting new coronavirus variant Omicron has been developed in India in partnership with Tata MD and the Indian Council of Medical Research (ICMR), said Dr Balram Bhargava, Director General of ICMR on Wednesday.
-
Centre Forms Panel To Frame New Law For Drugs, Cosmetics, Medical Devices
The government has constituted an eight-member panel to frame a new law for drugs, cosmetics and medical devices. The panel is being headed by Drugs Controller General of India (DCGI) Dr VG Somani.
-
Study On Mixing Covaxin, Covishield Gets Drug Regulator Approval
A study on mixing Covishield and Covaxin, the two main vaccines used in India's COVID-19 vaccination programme, has been given the go-ahead by the Drugs Controller General Of India (DCGI).
-
Drug Regulator Examining Zydus Cadila's Covid Vaccine For Children: Dr VK Paul
Drugs Controller General of India (DCGI) is examining pharmaceutical major Zydus Cadila's COVID-19 vaccine for children, said Dr VK Paul, Member-Health, Niti Aayog on Friday.
-
Foreign Vaccines Like Pfizer, Moderna A Step Closer With Key India Waiver
In a big move to clear the way for foreign vaccines like Pfizer and Moderna, the drug regulator has done away with the requirement of India-specific trials.
-
Need Of 3rd Anti-Covid Dose Based More Upon Conjecture Than Data: Experts
More data is needed to establish if a third anti-COVID-19 booster dose will more effectively help in fighting the surge in infections in the country as currently its requirement has been based more upon conjecture, health experts said.
